ResVita Bio Revenue and Competitors
Estimated Revenue & Valuation
- ResVita Bio's estimated annual revenue is currently $697.5k per year.
- ResVita Bio's estimated revenue per employee is $77,500
Employee Data
- ResVita Bio has 9 Employees.
- ResVita Bio grew their employee count by 80% last year.
ResVita Bio's People
Name | Title | Email/Phone |
---|---|---|
1 | Founder, CEO | Reveal Email/Phone |
2 | Principal Scientist | Reveal Email/Phone |
ResVita Bio Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $4.4M | 57 | -8% | $53M | N/A |
#2 | $21.2M | 137 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.3M | 15 | 15% | N/A | N/A |
#5 | $1.6M | 10 | -17% | N/A | N/A |
#6 | $0.7M | 9 | 50% | N/A | N/A |
#7 | $11.5M | 74 | -12% | N/A | N/A |
#8 | $0.4M | 275 | 10% | $236.7M | N/A |
#9 | $4M | 51 | -74% | $160M | N/A |
#10 | $2.3M | 15 | 15% | N/A | N/A |
What Is ResVita Bio?
The physical and emotional challenges of chronic skin diseases are devastating to patients, particularly children. ResVita Bio seeks to restore and maintain the vitality of the skin through engineered skin probiotics. Through synthetic biology and metabolic engineering, we are developing a safe and versatile skin microbial platform that continuously deliver therapies that address the causes of chronic skin diseases. \n\nResVita Bio is developing a rich product pipeline to treat inflammatory skin diseases like Netherton Syndrome, atopic dermatitis, psoriasis, acne, and rosacea.
keywords:N/AN/A
Total Funding
9
Number of Employees
$697.5k
Revenue (est)
80%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $0.7M | 9 | 0% | N/A |
#2 | $0.9M | 9 | -10% | N/A |
#3 | $0.1M | 9 | -18% | N/A |
#4 | $0.9M | 9 | 13% | N/A |
#5 | $1.4M | 9 | 0% | N/A |